Affinity DataIC50: 3nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae SC 12368 E-2More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae P99More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:Estimated IC50 values are as follows (obtained using STANDARD KINASEPROFILER).More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae P99More data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae SC 12368 E-2More data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae P99More data for this Ligand-Target Pair
Affinity DataIC50: 136nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 154nMAssay Description:Inhibition of IL-1 beta converting enzyme (ICE) in human blood monocytes expressed as KonMore data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae SC 12368 E-2More data for this Ligand-Target Pair
Affinity DataIC50: 308nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 361nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Enterobacter cloacae P99More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against beta-Lactamase enzyme derived from Escherichia coli WC3310 TEM-2More data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of MurI in wild type Helicobacter pylori J99More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair